A detailed history of Connable Office Inc transactions in Pfizer Inc stock. As of the latest transaction made, Connable Office Inc holds 30,097 shares of PFE stock, worth $804,793. This represents 0.09% of its overall portfolio holdings.

Number of Shares
30,097
Previous 44,562 32.46%
Holding current value
$804,793
Previous $1.25 Million 30.1%
% of portfolio
0.09%
Previous 0.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$27.7 - $31.39 $400,680 - $454,056
-14,465 Reduced 32.46%
30,097 $871,000
Q2 2024

Aug 06, 2024

BUY
$25.26 - $29.6 $1.13 Million - $1.32 Million
44,562 New
44,562 $1.25 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Connable Office Inc Portfolio

Follow Connable Office Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connable Office Inc with notifications on news.